Nuveen LLC Acquires New Position in DENTSPLY SIRONA Inc. $XRAY

Key Points

• Nuveen LLC purchased 421,639 shares of DENTSPLY SIRONA Inc., valued at approximately $6.3 million, representing a 0.21% stake in the company.
• DENTSPLY SIRONA reported earnings of $0.52 per share for the latest quarter, exceeding analyst estimates, but showed a 4.9% decline in quarterly revenue year-over-year.
• The company recently announced a quarterly dividend of $0.16 per share, yielding an annualized rate of 4.4%, with the ex-dividend date set for September 26th.

Nuveen LLC bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 421,639 shares of the medical instruments supplier's stock, valued at approximately $6,299,000. Nuveen LLC owned about 0.21% of DENTSPLY SIRONA at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the business. Quarry LP increased its holdings in DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after buying an additional 780 shares during the last quarter. Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA in the fourth quarter valued at $26,000. Covestor Ltd increased its holdings in DENTSPLY SIRONA by 17.5% in the first quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier's stock valued at $146,000 after buying an additional 1,456 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in DENTSPLY SIRONA in the first quarter valued at $25,000. Finally, Principal Financial Group Inc. increased its holdings in DENTSPLY SIRONA by 0.4% in the first quarter. Principal Financial Group Inc. now owns 457,397 shares of the medical instruments supplier's stock valued at $6,834,000 after buying an additional 1,708 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY traded down $0.02 during midday trading on Friday, reaching $14.30. 1,864,538 shares of the company were exchanged, compared to its average volume of 3,832,729. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $27.48. The stock has a fifty day simple moving average of $15.15 and a 200 day simple moving average of $15.32. The stock has a market cap of $2.85 billion, a P/E ratio of -3.02, a PEG ratio of 0.89 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. During the same quarter last year, the company posted $0.49 earnings per share. The business's revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.5%. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -13.50%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on XRAY shares. Wells Fargo & Company dropped their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a report on Friday, August 8th. Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Barrington Research dropped their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a report on Friday, August 8th. UBS Group dropped their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a report on Monday, July 21st. Two research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $18.64.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.